PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionThe CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so.
CitationDoshi, P. (2013). Influenza: marketing vaccine by marketing disease. BMJ 2013;346:f3037. DOI: https://doi.org/10.1136/bmj.f3037
KeywordCenters for Disease Control and Prevention (U.S.)
Influenza, Human--prevention & control
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/6608
- [Influenza vaccination for all older than 65 years--utopia or possibility].
- Authors: Malmvall BE, Abom PE
- Issue date: 2004 Dec 23
- Our national obsession with flu vaccine.
- Authors: Stephens P
- Issue date: 2013 Sep
- Influenza vaccination trends among adults 65 years or older in the United States, 1989-2002.
- Authors: Lu PJ, Singleton JA, Rangel MC, Wortley PM, Bridges CB
- Issue date: 2005 Sep 12
- Survey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics.
- Authors: Jacobson SH, Sewell EC, Jokela JA
- Issue date: 2007 Dec
- [The flu: should all be vaccinated?].
- Authors: Cisterna R
- Issue date: 2009 Nov